BRAND NAME ANNUAL REPORT: 2024 EMA EDITION

The Brand Name Annual Report: EMA Edition 2024 provides a comprehensive analysis of 89 newly approved brand names from the European Medicines Agency (EMA). This exclusive report offers valuable insights into name safety, promotional impact, and naming strategies, helping pharmaceutical professionals navigate the evolving landscape of regulatory-approved brand names.

✅In-depth analysis of 89 newly approved EMA brand names

✅Name safety testing results (sound-alike and look-alike risks)

✅Brand name strategy insights – derivation, promotional messaging, and therapeutic categories

✅Regulatory perspectives to enhance your naming process

✅A must-read for pharma professionals, brand strategists, and regulatory teams

1. Stay informed about the latest EMA-approved brand names

2. Avoid naming pitfalls with expert insights on similarity risks

3. Enhance regulatory success with strategic recommendations

Download the Report Now and gain expert insights into EMA’s 2024 pharmaceutical brand name approvals.

Brandsymbol All rights reserved © 2025